The e/sQTL results imply that increased expression of CDKN2A, decreased expression of CDKN2B, and exon skipping in CDKN2B-AS1 may increase POAG risk (Fig. 3, Supplementary Figs. 5a and 11). Here, CDKN2B is linked to open-angle glaucoma.